Literature DB >> 9618170

Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy.

K Yoshida1, A Nakamura, M Yazaki, S Ikeda, S Takeda.   

Abstract

X-linked dilated cardiomyopathy (XLDCM) is a clinical phenotype of dystrophinopathy which is characterized by preferential myocardial involvement without any overt clinical signs of skeletal myopathy. To date, several mutations in the Duchenne muscular dystrophy gene, DMD , have been identified in patients with XLDCM, but a pathogenic correlation of these cardiospecific mutations in DMD with the XLDCM phenotype has remained to be elucidated. We report here the identification of a unique de novo L1 insertion in the muscle exon 1 in DMD in three XLDCM patients from two unrelated Japanese families. The insertion was a 5'-truncated form of human L1 inversely integrated in the 5'-untranslated region in the muscle exon 1, which affected the transcription or the stability of the muscle form of dystrophin transcripts but not that of the brain or Purkinje cell form, probably due to its unique site of integration. We speculate that this insertion of an L1 sequence in DMD is responsible for some of the population of Japanese patients with XLDCM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618170     DOI: 10.1093/hmg/7.7.1129

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  30 in total

1.  Determination of L1 retrotransposition kinetics in cultured cells.

Authors:  E M Ostertag; E T Prak; R J DeBerardinis; J V Moran; H H Kazazian
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Genomic characterization of recent human LINE-1 insertions: evidence supporting random insertion.

Authors:  I Ovchinnikov; A B Troxel; G D Swergold
Journal:  Genome Res       Date:  2001-12       Impact factor: 9.043

3.  Conserved regions of the DMD 3' UTR regulate translation and mRNA abundance in cultured myotubes.

Authors:  C Aaron Larsen; Michael T Howard
Journal:  Neuromuscul Disord       Date:  2014-05-22       Impact factor: 4.296

4.  Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy.

Authors:  E L Hanson; R E Hershberger
Journal:  J Genet Couns       Date:  2001-10       Impact factor: 2.537

Review 5.  Genetic abnormalities responsible for dilated cardiomyopathy.

Authors:  J A Towbin; N E Bowles
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

6.  Mobile DNA in Endocrinology: LINE-1 Retrotransposon Causing Partial Androgen Insensitivity Syndrome.

Authors:  Rafael Loch Batista; Katsumi Yamaguchi; Andresa di Santi Rodrigues; Mirian Yumie Nishi; John L Goodier; Luciani Renata Carvalho; Sorahia Domenice; Elaine M F Costa; Haig H Kazazian; Berenice Bilharinho Mendonca
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

Review 7.  Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.

Authors:  N Cohen; F Muntoni
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

8.  Mobilizing diversity: transposable element insertions in genetic variation and disease.

Authors:  Kathryn A O'Donnell; Kathleen H Burns
Journal:  Mob DNA       Date:  2010-09-02

9.  A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy.

Authors:  Satu Kärkkäinen; Raija Miettinen; Petri Tuomainen; Päivi Kärkkäinen; Tiina Heliö; Eeva Reissell; Maija Kaartinen; Lauri Toivonen; Markku S Nieminen; Johanna Kuusisto; Markku Laakso; Keijo Peuhkurinen
Journal:  J Mol Med (Berl)       Date:  2003-10-15       Impact factor: 4.599

10.  Active Alu element "A-tails": size does matter.

Authors:  Astrid M Roy-Engel; Abdel-Halim Salem; Oluwatosin O Oyeniran; Lisa Deininger; Dale J Hedges; Gail E Kilroy; Mark A Batzer; Prescott L Deininger
Journal:  Genome Res       Date:  2002-09       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.